Hearing Loss Trial, Recruiting (NCT06400992)

Hearing Loss Trial, Recruiting NCT06400992 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06400992 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Be between 6 and 16 years old at the time of joining the trial
Speak French as their main way of communicating
Be able to complete a specific French hearing test called the Simplified French Matrix test in Noise
(One group) Use or be eligible to upgrade to a Sky cochlear implant processor on one ear, and wear a hearing aid in the other ear
(Another group) Use or be eligible to upgrade to two Sky cochlear implant processors, one on each ear
Have a parent or legal guardian who agrees and signs a consent form
Be covered by a health insurance plan or be eligible for one

Who may not be able to join:

Children who have been identified as having a serious neurological condition (a condition affecting the brain or nervous system) before joining, detected through brain scans or specialist assessments
Children who have been identified as having severe cognitive (thinking/learning), psychiatric (mental health), or developmental difficulties before joining
Families who do not understand French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nathalie LOUNDON, MD,PhD, APHP

Phone: 01 71 39 67 82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06400992

Sponsor: Assistance Publique - Hôpitaux de Paris

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 01 71 39 67 82

More information: https://clinicaltrials.gov/study/NCT06400992

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Be between 6 and 16 years old at the time of joining the trial
Speak French as their main way of communicating
Be able to complete a specific French hearing test called the Simplified French Matrix test in Noise
(One group) Use or be eligible to upgrade to a Sky cochlear implant processor on one ear, and wear a hearing aid in the other ear
(Another group) Use or be eligible to upgrade to two Sky cochlear implant processors, one on each ear
Have a parent or legal guardian who agrees and signs a consent form
Be covered by a health insurance plan or be eligible for one

Who may not be able to join:

Children who have been identified as having a serious neurological condition (a condition affecting the brain or nervous system) before joining, detected through brain scans or specialist assessments
Children who have been identified as having severe cognitive (thinking/learning), psychiatric (mental health), or developmental difficulties before joining
Families who do not understand French

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique - Hôpitaux de Paris

Registry

ClinicalTrials.gov

Start date

11 December 2024

Est. completion

11 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Speech in noise perception (FraSimat)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov